Use of the intubating laryngeal mask airway: Are muscle relaxants necessary?

Janet M. Van Vlymen, Margarita Coloma, W. Kendall Tongier, Paul F. White

Research output: Contribution to journalArticle

30 Citations (Scopus)

Abstract

Background: The intubating laryngeal mask airway (ILMA) is designed to facilitate blind tracheal intubation. The effect of a muscle relaxant on the ability to perform tracheal intubation through the ILMA device has not been previously evaluated. This randomized, double-blind, placebo-controlled study was designed to evaluate rocuronium, 0.2 or 0.4 mg/kg administered intravenously, on the success rate and incidence of complications associated with ILMA-assisted tracheal intubation. Methods: A total of 75 healthy patients were induced with propofol 2 mg/kg and fentanyl 1 μg/kg intravenously. After insertion of the ILMA device, patients were administered either saline, rocuronium 0.2 mg/kg, or rocuronium 0.4 mg/kg in a total volume of 5 ml. At 90 s after administration of the study drug, tracheal intubation was attempted using a disposable polyvinyl tube. If unsuccessful, a reusable silicone tube was tried. In addition to recording the time and number of attempts required to secure the airway, the incidence of complications during placement of the tracheal tube and removal of the ILMA were noted. Results: Tracheal intubation was successful in 76-96% of the patients. The overall success rates and times required to secure the airway were similar in all three treatment groups. The High-dose rocuronium group experienced less patient movement (8 vs. 28 and 48%) and coughing (12 vs. 20 and 52%) than the low-dose rocuronium and saline groups, respectively. Use of rocuronium was also associated with a dose-related decrease in the requirement for supplemental bolus doses of propofol during intubation and removal of the ILMA device. Conclusions: Use of rocuronium did not significantly improve the success rate in performing tracheal intubation through the ILMA. However, it produced dose-related decreases in coughing and movement after tracheal intubation and reduced difficulties associated with removal of the ILMA device.

Original languageEnglish (US)
Pages (from-to)340-345
Number of pages6
JournalAnesthesiology
Volume93
Issue number2
StatePublished - 2000

Fingerprint

Laryngeal Masks
Intubation
Muscles
Equipment and Supplies
Propofol
Polyvinyls
Incidence
Fentanyl
Silicones
rocuronium
Placebos

Keywords

  • Airway management
  • Blockade
  • Neuromuscular transmission

ASJC Scopus subject areas

  • Anesthesiology and Pain Medicine

Cite this

Van Vlymen, J. M., Coloma, M., Tongier, W. K., & White, P. F. (2000). Use of the intubating laryngeal mask airway: Are muscle relaxants necessary? Anesthesiology, 93(2), 340-345.

Use of the intubating laryngeal mask airway : Are muscle relaxants necessary? / Van Vlymen, Janet M.; Coloma, Margarita; Tongier, W. Kendall; White, Paul F.

In: Anesthesiology, Vol. 93, No. 2, 2000, p. 340-345.

Research output: Contribution to journalArticle

Van Vlymen, JM, Coloma, M, Tongier, WK & White, PF 2000, 'Use of the intubating laryngeal mask airway: Are muscle relaxants necessary?', Anesthesiology, vol. 93, no. 2, pp. 340-345.
Van Vlymen, Janet M. ; Coloma, Margarita ; Tongier, W. Kendall ; White, Paul F. / Use of the intubating laryngeal mask airway : Are muscle relaxants necessary?. In: Anesthesiology. 2000 ; Vol. 93, No. 2. pp. 340-345.
@article{ce69d4f3181a43339649e63268ba9800,
title = "Use of the intubating laryngeal mask airway: Are muscle relaxants necessary?",
abstract = "Background: The intubating laryngeal mask airway (ILMA) is designed to facilitate blind tracheal intubation. The effect of a muscle relaxant on the ability to perform tracheal intubation through the ILMA device has not been previously evaluated. This randomized, double-blind, placebo-controlled study was designed to evaluate rocuronium, 0.2 or 0.4 mg/kg administered intravenously, on the success rate and incidence of complications associated with ILMA-assisted tracheal intubation. Methods: A total of 75 healthy patients were induced with propofol 2 mg/kg and fentanyl 1 μg/kg intravenously. After insertion of the ILMA device, patients were administered either saline, rocuronium 0.2 mg/kg, or rocuronium 0.4 mg/kg in a total volume of 5 ml. At 90 s after administration of the study drug, tracheal intubation was attempted using a disposable polyvinyl tube. If unsuccessful, a reusable silicone tube was tried. In addition to recording the time and number of attempts required to secure the airway, the incidence of complications during placement of the tracheal tube and removal of the ILMA were noted. Results: Tracheal intubation was successful in 76-96{\%} of the patients. The overall success rates and times required to secure the airway were similar in all three treatment groups. The High-dose rocuronium group experienced less patient movement (8 vs. 28 and 48{\%}) and coughing (12 vs. 20 and 52{\%}) than the low-dose rocuronium and saline groups, respectively. Use of rocuronium was also associated with a dose-related decrease in the requirement for supplemental bolus doses of propofol during intubation and removal of the ILMA device. Conclusions: Use of rocuronium did not significantly improve the success rate in performing tracheal intubation through the ILMA. However, it produced dose-related decreases in coughing and movement after tracheal intubation and reduced difficulties associated with removal of the ILMA device.",
keywords = "Airway management, Blockade, Neuromuscular transmission",
author = "{Van Vlymen}, {Janet M.} and Margarita Coloma and Tongier, {W. Kendall} and White, {Paul F.}",
year = "2000",
language = "English (US)",
volume = "93",
pages = "340--345",
journal = "Anesthesiology",
issn = "0003-3022",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

TY - JOUR

T1 - Use of the intubating laryngeal mask airway

T2 - Are muscle relaxants necessary?

AU - Van Vlymen, Janet M.

AU - Coloma, Margarita

AU - Tongier, W. Kendall

AU - White, Paul F.

PY - 2000

Y1 - 2000

N2 - Background: The intubating laryngeal mask airway (ILMA) is designed to facilitate blind tracheal intubation. The effect of a muscle relaxant on the ability to perform tracheal intubation through the ILMA device has not been previously evaluated. This randomized, double-blind, placebo-controlled study was designed to evaluate rocuronium, 0.2 or 0.4 mg/kg administered intravenously, on the success rate and incidence of complications associated with ILMA-assisted tracheal intubation. Methods: A total of 75 healthy patients were induced with propofol 2 mg/kg and fentanyl 1 μg/kg intravenously. After insertion of the ILMA device, patients were administered either saline, rocuronium 0.2 mg/kg, or rocuronium 0.4 mg/kg in a total volume of 5 ml. At 90 s after administration of the study drug, tracheal intubation was attempted using a disposable polyvinyl tube. If unsuccessful, a reusable silicone tube was tried. In addition to recording the time and number of attempts required to secure the airway, the incidence of complications during placement of the tracheal tube and removal of the ILMA were noted. Results: Tracheal intubation was successful in 76-96% of the patients. The overall success rates and times required to secure the airway were similar in all three treatment groups. The High-dose rocuronium group experienced less patient movement (8 vs. 28 and 48%) and coughing (12 vs. 20 and 52%) than the low-dose rocuronium and saline groups, respectively. Use of rocuronium was also associated with a dose-related decrease in the requirement for supplemental bolus doses of propofol during intubation and removal of the ILMA device. Conclusions: Use of rocuronium did not significantly improve the success rate in performing tracheal intubation through the ILMA. However, it produced dose-related decreases in coughing and movement after tracheal intubation and reduced difficulties associated with removal of the ILMA device.

AB - Background: The intubating laryngeal mask airway (ILMA) is designed to facilitate blind tracheal intubation. The effect of a muscle relaxant on the ability to perform tracheal intubation through the ILMA device has not been previously evaluated. This randomized, double-blind, placebo-controlled study was designed to evaluate rocuronium, 0.2 or 0.4 mg/kg administered intravenously, on the success rate and incidence of complications associated with ILMA-assisted tracheal intubation. Methods: A total of 75 healthy patients were induced with propofol 2 mg/kg and fentanyl 1 μg/kg intravenously. After insertion of the ILMA device, patients were administered either saline, rocuronium 0.2 mg/kg, or rocuronium 0.4 mg/kg in a total volume of 5 ml. At 90 s after administration of the study drug, tracheal intubation was attempted using a disposable polyvinyl tube. If unsuccessful, a reusable silicone tube was tried. In addition to recording the time and number of attempts required to secure the airway, the incidence of complications during placement of the tracheal tube and removal of the ILMA were noted. Results: Tracheal intubation was successful in 76-96% of the patients. The overall success rates and times required to secure the airway were similar in all three treatment groups. The High-dose rocuronium group experienced less patient movement (8 vs. 28 and 48%) and coughing (12 vs. 20 and 52%) than the low-dose rocuronium and saline groups, respectively. Use of rocuronium was also associated with a dose-related decrease in the requirement for supplemental bolus doses of propofol during intubation and removal of the ILMA device. Conclusions: Use of rocuronium did not significantly improve the success rate in performing tracheal intubation through the ILMA. However, it produced dose-related decreases in coughing and movement after tracheal intubation and reduced difficulties associated with removal of the ILMA device.

KW - Airway management

KW - Blockade

KW - Neuromuscular transmission

UR - http://www.scopus.com/inward/record.url?scp=0033860931&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033860931&partnerID=8YFLogxK

M3 - Article

C2 - 10910479

AN - SCOPUS:0033860931

VL - 93

SP - 340

EP - 345

JO - Anesthesiology

JF - Anesthesiology

SN - 0003-3022

IS - 2

ER -